These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4233114)

  • 1. [On electrorheographic objectivization of the long term effect of a retarding type of beta-pyridine carbonic acid].
    Algan O; Ayturan F; Kienle H
    Med Welt; 1967 Feb; 6():342-5. PubMed ID: 4233114
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonged effect of oxymethylamide of pyridine 3-carbonic acid in the management of hepato biliary cholestatic-cholangitic processes].
    Cerullo E; Satriano J; Valdes EF
    Prensa Med Argent; 1968 Jul; 55(22):1052-5. PubMed ID: 4238940
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
    Modica G; Ferrante R
    Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of the therapeutic activity of the beta-pyridyl-carbinolic ester of clofibric acid].
    Silingardi V; Renzi R; Mora A; Di Prisco AU
    Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4579325
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of beta-pyridyl carbinol (Ronicol Timespan)].
    Kobayashi K; Shibata M; Kato K; Kawaguchi S; Sasa R
    Saishin Igaku; 1969 Dec; 24(12):2530-4. PubMed ID: 5363412
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term management of symptoms of cerebral arteriosclerosis.
    Stern FH
    Geriatrics; 1971 Jul; 26(7):98-103. PubMed ID: 4253476
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of age and sex on temporal heart dynamics and blood pressure in persons with a normal heart and those suffering from hypertension].
    Kaschani-Zadeh D
    Arztl Forsch; 1965 Nov; 19(11):586-602. PubMed ID: 5899393
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the antibacterial activity of pyridin-3-carbonic acid oxymethylamide (Nikoform, Bilamid, Felosan) in the treatment of urinary tract infections].
    Otto-Unger G; Patsch R; Metzke H; Höhne C
    Dtsch Gesundheitsw; 1971 Jan; 26(1):29-31. PubMed ID: 4255538
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new pharmacological association in therapy of dyslipidemic and arteriosclerotic syndromes].
    Cucinotta D
    Minerva Med; 1972 Feb; 63(15):870-85. PubMed ID: 4259330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies with Seniosan in arteriosclerosis of the abdominal aorta and-or lower extremities].
    Blomquist HE
    Ann Chir Gynaecol Fenn; 1968; 57(2):218-20. PubMed ID: 4237173
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of arteriosclerosis].
    Knüchel F
    Med Welt; 1969 Dec; 52():2817-8. PubMed ID: 5371544
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of age, sex, body size and diseases on the stroke volume determination according to Wezler and Böger and according to Brömser and Ranke].
    Grässner H; Jungmann H
    Z Kreislaufforsch; 1965 Aug; 54(8):777-82. PubMed ID: 5864999
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in arterial pressure, minute blood volume and peripheral resistance in atherosclerotic patients following physical therapy].
    Seliuminova NIa
    Ter Arkh; 1968 Feb; 40(2):60-3. PubMed ID: 5675774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of pyridinolcarbamate in the treatment of diabetic angiopathies and atheromatous arteritis].
    Plauchu M; Bussy L; Rondelet J
    Lyon Med; 1972 Feb; 227(3):271-7. PubMed ID: 5037162
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of experimental and human athero- sclerosis by a bradykinin antagonist, pyridinol carbamate. (Preliminary report)].
    Shimamoto T; Numano F; Fujita T; Atsumi T
    Rev Atheroscler (Paris); 1967; 9(2):294-306. PubMed ID: 6064255
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long term treatment of arteriosclerotically induced circulatory disorders of the retina and choroid with vitamins A + E as well as a nicotinic acid derivative].
    Kager S
    Klin Monbl Augenheilkd; 1968; 153(4):571-7. PubMed ID: 4975191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic activity of a combination of nicotinyl alcohol, vitamin A and vitamin E in atherosclerotic arteriopathies].
    Putignano G
    Clin Ter; 1980 Aug; 94(3):275-82. PubMed ID: 7449347
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the use of an arterial wall extract (Liovasal) in the therapy of some retinal vascular diseases].
    Vitali G; Deledda MG
    Ann Ottalmol Clin Ocul; 1967 Dec; 93(12):1413-29. PubMed ID: 5605996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.